Review your goals, medical history, and personalized treatment plan with a provider
Tirzepatide activates both GLP-1 and GIP pathways simultaneously, offering redundant hunger-blocking signals that work synergistically
There is currently no official regulatory guidance from the MHRA, NICE, or EMA specifically addressing retatrutide, as the drug has not yet received marketing authorisation in the United Kingdom or European Union
Excessive thirst, rapid blood sugar spikes, or energy crashes after banana consumption suggest the carbohydrate load is too high for your current dose or metabolic state
In-person visits, physical exams, urgent care, and emergency services are outside the scope of the platform